Haemonetics (HAE) Inventory (2010 - 2026)

Haemonetics has reported Inventory for 17 years, with the latest figure at $306.4 million in Q1 2026.

• For the quarter ending Q1 2026, Inventory fell 16.1% year-over-year to $306.4 million; the trailing twelve-month figure through Mar 2026 stood at $306.4 million (down 16.1% YoY), and the FY2026 full-year result was $306.4 million, down 16.1% from the prior year.
• Inventory for Q1 2026 stood at $306.4 million, down from $321.2 million in the prior quarter.
• The five-year high for Inventory was $382.1 million in Q3 2024, with the low at -$26.4 million in Q4 2024.
• Average Inventory over 5 years is $292.3 million, with a median of $304.9 million recorded in 2022.
• Year-over-year, Inventory plunged 108.68% in 2024 and jumped 1316.61% in 2025.
• Tracing HAE's Inventory over 5 years: stood at $255.8 million in 2022, then increased by 18.87% to $304.0 million in 2023, then sank by 108.68% to -$26.4 million in 2024, then jumped by 1316.61% to $321.2 million in 2025, then slipped by 4.61% to $306.4 million in 2026.
• The last three Inventory figures came in at $306.4 million (Q1 2026), $321.2 million (Q4 2025), and $336.2 million (Q3 2025), per Business Quant data.

Peer Comparison